SCHEMBL17508158

SCHEMBL17508158

Cc1ccc(SCc2ccc(C=O)cc2)c(C)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.46
LMNA P02545 5/20 0.40
SMN1; SMN2 Q16637 5/20 0.40
ALDH1A1 P00352 5/20 0.40
HPGD P15428 3/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
HTT P42858 1/20 0.40
RAB9A P51151 4/20 0.39
NPC1 O15118 3/20 0.39
POLB P06746 1/20 0.39
MAPT P10636 3/20 0.36
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
DAO P14920 1/20 0.35
GAA P10253 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20704671 0.77 CYP2A6 (0.57) CYP2A6LMNASMN1; SMN2ALDH1A1HPGD
SCHEMBL17508118 0.75 MAOA (0.41) CYP2A6LMNASMN1; SMN2ALDH1A1HPGD
SCHEMBL2558050 0.75 LPL (0.46) LMNASMN1; SMN2ALDH1A1RAB9ANPC1
SCHEMBL15795270 0.72 CYP2A6 (0.39) CYP2A6LMNAALDH1A1HPGDMAPT
SCHEMBL7691152 0.71 LMNA (0.47) LMNASMN1; SMN2CYP1A2CYP2C9HTT
P-Xylene SCHEMBL7180224 0.70 CYP2A6 (0.70) CYP2A6LMNASMN1; SMN2ALDH1A1HPGD
SCHEMBL20171522 0.69 LMNA (0.45) LMNASMN1; SMN2ALDH1A1HPGDRAB9A
SCHEMBL20546774 0.69 CYP2A6 (0.76) CYP2A6LMNASMN1; SMN2ALDH1A1HPGD
SCHEMBL9515924 0.69 LMNA (0.45) LMNASMN1; SMN2ALDH1A1HPGDRAB9A
SCHEMBL10680644 0.69 RAB9A (0.53) SMN1; SMN2ALDH1A1HTTRAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016019588-A1 OXACAZONE COMPOUNDS TO TREAT CLOSTRIDIUM DIFFICILE THE BROAD INSTITUTE, INC. (US) 2016-02-11 WO disclosed
WO-2016019588-A1 OXACAZONE COMPOUNDS TO TREAT CLOSTRIDIUM DIFFICILE THE BROAD INSTITUTE, INC. (US) 2016-02-11 WO disclosed